2478

antibody from Cell Signaling Technology, Inc

Targeting: KDR CD309, FLK1, VEGFR, VEGFR2

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

2478

Provider

Cell Signaling Technology, Inc

Proper citation

Cell Signaling Technology Cat#2478, RRID:AB_331377

Product name

Phospho-VEGF Receptor 2 (Tyr1175) (19A10) Rabbit mAb

Antibody type

Monoclonal

Reactivity

Human, Mouse

Host

Rabbit

Storage

-20°C

References

Submitted references

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.

Antonescu CR, Yoshida A, Guo T, Chang NE, Zhang L, Agaram NP, Qin LX, Brennan MF, Singer S, Maki RG
Cancer research 2009 Sep 15;69(18):7175-9

---

The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching.

Kappas NC, Zeng G, Chappell JC, Kearney JB, Hazarika S, Kallianos KG, Patterson C, Annex BH, Bautch VL
The Journal of cell biology 2008 Jun 2;181(5):847-58